GlassScriptPhysician profile
Heather M Kidd
NPI 1720440977
$1,466.31
in general payments reported to CMS, 2019-2025
16 companies · $1,423 in 2025
The $1,423 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.56 · 2020: $23.32 · 2025: $1,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $321.92 | 2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $176.06 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Boston Scientific Corporation | $141.33 | 2025 | General - Pain Management |
| Glaxosmithkline, LLC. | $136.56 | 2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $127.37 | 2025 | |
| Lilly USA, LLC | $114.04 | 2025 | Mounjaro, Zepbound |
| Abbvie INC. | $102.93 | 2025 | |
| Exact Sciences Corporation | $90.52 | 2025 | The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $76.39 | 2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $41.13 | 2025 | Voquezna |
| Amgen INC. | $36.33 | 2025 | Repatha, Otezla |
| Dexcom, INC. | $30.53 | 2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $22.67 | 2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.56 | 2019 | |
| Esperion Therapeutics, INC. | $15.07 | 2025 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $13.90 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Kidd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.